The Influence of Dexmedetomidine as an Adjuvant in Intrathecal Labor Analgesia: A Multicenter Study on Efficacy and Maternal Satisfaction
The Journal of Clinical Pharmacology · 2024
DOI: 10.1002/jcph.2335 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift The Journal of Clinical Pharmacology, 2024. Verfasst von Chengyi Lao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Nanning Maternal and Child Health Hospital, Nanning, China. Hauptthemen laut MEDLINE: Dexmedetomidine, Analgesia, Epidural. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 15 Literaturangaben.
Abstract (Originalsprache)
In this study, we examined the impact of dexmedetomidine (DEX) on the effectiveness of epidural analgesia and labor outcomes. We administered different doses of DEX combined with 0.1% ropivacaine for epidural analgesia to evaluate the clinical effects and safety. To assess the effects of different concentrations of DEX in parturient women receiving epidural analgesia, we conducted a randomized double‐blind trial. We selected 400 parturient women and randomly assigned them to 4 groups, with 100 parturient women in each group: S0.1 (0.1 µg/mL DEX), S0.2 (0.2 µg/mL DEX), S0.3 (0.3 µg/mL DEX), and a control group (0.3 µg/mL sufentanil). Post‐analgesia, we recorded the Bromage score, duration of labor, method of delivery, bleeding, neonatal Apgar score, adverse reactions, and maternal satisfaction. The number of patients with a Bromage score of ≥2 and the incidence of bradycardia were higher in the S0.3 group compared with the other 3 groups ( P < .05), whereas the high satisfaction rate was lower in the S0.3 group ( P < .05). Moreover, we found that the number of times that additional patient‐controlled analgesia was administered was higher in the S0.1 group compared with the remaining 3 groups ( P < .05). The control group exhibited a higher incidence of pruritus than the other 3 groups ( P < .05). In conclusion, when administering spinal anesthesia for the relief of labor pain, epidural analgesia with 0.1% ropivacaine combined with 0.2 µg/mL DEX provides relatively ideal analgesic effects, higher maternal satisfaction, and reduces the incidence of pruritus, compared with the combination of 0.1% ropivacaine and 0.3 µg/mL sufentanil.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, Nanning Maternal and Child Health Hospital, Nanning, China.
- Department of Obstetrics, Nanning Maternal and Child Health Hospital, Nanning, China.
- Department of Anesthesiology, Hangzhou Maternal and Child Health Hospital, Hangzhou, China.
- Department of Anesthesiology, Nanning Wuming District Maternal and Child Health Hospital, Nanning, China.
ORCID-Profile: Maoling Zhu
Zitieren
APA
Lao, C., Zhu, M., Yang, Y., Lin, X., Huang, R., Wei, X., & Wei, X. (2024). The Influence of Dexmedetomidine as an Adjuvant in Intrathecal Labor Analgesia: A Multicenter Study on Efficacy and Maternal Satisfaction. The Journal of Clinical Pharmacology. https://doi.org/10.1002/jcph.2335
Vancouver
Lao C, Zhu M, Yang Y, Lin X, Huang R, Wei X, et al. The Influence of Dexmedetomidine as an Adjuvant in Intrathecal Labor Analgesia: A Multicenter Study on Efficacy and Maternal Satisfaction. The Journal of Clinical Pharmacology. 2024. doi:10.1002/jcph.2335
BibTeX
@article{Lao2024,
author = {Lao, Chengyi and Zhu, Maoling and Yang, Yu and Lin, Xuejiang and Huang, Ruiping and Wei, Xiaofen and Wei, Xiaoyu},
title = {The Influence of Dexmedetomidine as an Adjuvant in Intrathecal Labor Analgesia: A Multicenter Study on Efficacy and Maternal Satisfaction},
journal = {The Journal of Clinical Pharmacology},
year = {2024},
doi = {10.1002/jcph.2335}
}
EUVIMED